Madan Katragadda

781 total citations
23 papers, 642 citations indexed

About

Madan Katragadda is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Madan Katragadda has authored 23 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in Madan Katragadda's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Photoreceptor and optogenetics research (6 papers) and CAR-T cell therapy research (6 papers). Madan Katragadda is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Photoreceptor and optogenetics research (6 papers) and CAR-T cell therapy research (6 papers). Madan Katragadda collaborates with scholars based in United States, United Kingdom and Canada. Madan Katragadda's co-authors include John D. Lambris, Philip L. Yèagle, Georgia Sfyroera, James L. Alderfer, Dimitrios Morikis, Paola Magotti, Arlene D. Albert, Stuart N. Isaacs, Mark W. Maciejewski and Buddhadeb Mallik and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Madan Katragadda

23 papers receiving 629 citations

Peers

Countries citing papers authored by Madan Katragadda

Since Specialization

Citations

This map shows the geographic impact of Madan Katragadda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madan Katragadda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madan Katragadda more than expected).

Fields of papers citing papers by Madan Katragadda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madan Katragadda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madan Katragadda. The network helps show where Madan Katragadda may publish in the future.

Co-authorship network of co-authors of Madan Katragadda

This figure shows the co-authorship network connecting the top 25 collaborators of Madan Katragadda. A scholar is included among the top collaborators of Madan Katragadda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madan Katragadda. Madan Katragadda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 2357: T cell receptor beta chain-directed Tri-specific antibody molecules retarget V-beta T cell subsets to tumors to promote potent and durable antitumor activity 2024 ·Cancer Research ·Madan Katragadda, Jacques Moisan, Gurkan Guntas, (unknown), (unknown), (unknown), (unknown), Kent Nybakken, (unknown), (unknown), Kevin M. Chin, (unknown), (unknown)	1
2	Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials 2023 ·Science Advances ·Pierre Vantourout, (unknown), (unknown), Thomas S. Hayday, Adam Laing, Khiyam Hussain, Rosamond Nuamah, Shichina Kannambath, Jacques Moisan, A. Allart Stoop, Sebastiano Battaglia, (unknown), (unknown), (unknown), Madan Katragadda, Adrian Hayday	3
3	A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity 2023 ·Science Translational Medicine ·(unknown), Renee N. Donahue, Madan Katragadda, (unknown), Wei Huang, (unknown), Gurkan Guntas, J. Tang, (unknown), Jacques Moisan, (unknown), A. Allart Stoop, Sangeetha Palakurthi, (unknown), (unknown), E. John Wherry, (unknown), James L. Gulley, (unknown), Jeffrey Schlom	10
4	Trial START-001: A phase 1/2 study of STAR0602, a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors post checkpoint inhibitor (CPI) treatment. 2023 ·Journal of Clinical Oncology ·Ryan J. Sullivan, Ke Liu, Jason M. Redman, Nicholas Tschernia, (unknown), (unknown), (unknown), Madan Katragadda, Jacques Moisan, Rajesh Chopra, Aurélien Marabelle, Howard L. Kaufman, Lillian L. Siu, (unknown), James L. Gulley	1
5	1392 An atypical central memory like phenotype can be induced in human T cells by Innate TCRαβ engagement 2022 ·Regular and Young Investigator Award Abstracts ·Khiyam Hussain, Pierre Vantourout, (unknown), (unknown), Thomas S. Hayday, Adam Laing, (unknown), Madan Katragadda, (unknown), Jonathan C. Hsu, Adrian Hayday	1
6	Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics 2017 ·mAbs ·Nicole Piche‐Nicholas, Lindsay B. Avery, Amy King, (unknown), Mengmeng Wang, Denise M. O’Hara, Lioudmila Tchistiakova, Madan Katragadda	61
7	Abstract 3095: The development of CPI as a novel, next-generation DNA-targeting payload for ADCs 2017 ·Cancer Research ·Jennifer Kahler, Maureen Dougher, (unknown), (unknown), Andreas Maderna, Russell G. Dushin, Stéphane Thibault, Mauricio Leal, Madan Katragadda, Christopher J. O’Donnell, Matthew Sung, Puja Sapra	1
8	Preclinical Studies of Pf-04849285, An Interferon-α8 Fusion Protein for the Treatment of HCV 2012 ·Antiviral Therapy ·María Victoria Flores, Timothy P. Hickling, Sasha Sreckovic, Mark Fidock, Nigel Horscroft, Madan Katragadda, (unknown), (unknown), (unknown), Nicola Robas, (unknown), (unknown), Michael T. Lawton, John Marcek, (unknown), Michael Westby, Giuseppe Ciaramella	4
9	Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development 2010 ·Hepatology Research ·Shinji Ogawa, Takashi Ochi, Hideaki Shimada, (unknown), (unknown), Aisuke Nii, Mark Moffat, Madan Katragadda, Bernard N. Violand, Robert H. Arch, Jaime L. Masferrer	54
10	Hydrophobic Effect and Hydrogen Bonds Account for the Improved Activity of a Complement Inhibitor, Compstatin 2006 ·Journal of Medicinal Chemistry ·Madan Katragadda, Paola Magotti, Georgia Sfyroera, John D. Lambris	97
11	Electrostatic Modeling Predicts the Activities of Orthopoxvirus Complement Control Proteins 2005 ·The Journal of Immunology ·Georgia Sfyroera, Madan Katragadda, Dimitrios Morikis, Stuart N. Isaacs, John D. Lambris	63
12	Expression of compstatin in Escherichia coli: Incorporation of unnatural amino acids enhances its activity 2005 ·Protein Expression and Purification ·Madan Katragadda, John D. Lambris	19
13	Structural studies of the putative helix 8 in the human $beta;2 adrenergic receptor: an NMR study 2004 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Madan Katragadda	1
14	Structural studies of the putative helix 8 in the human β2 adrenergic receptor: an NMR study 2004 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Madan Katragadda, Mark W. Maciejewski, Philip L. Yèagle	32
15	Design and NMR Characterization of Active Analogues of Compstatin Containing Non-Natural Amino Acids 2004 ·Journal of Medicinal Chemistry ·Buddhadeb Mallik, Madan Katragadda, Lynn A. Spruce, (unknown), (unknown), Dimitrios Morikis, John D. Lambris	60
16	Thermodynamic Studies on the Interaction of the Third Complement Component and Its Inhibitor, Compstatin 2004 ·Journal of Biological Chemistry ·Madan Katragadda, Dimitrios Morikis, John D. Lambris	22
17	A soluble peripherin/Rds C-terminal polypeptide promotes membrane fusion and changes conformation upon membrane association 2003 ·Experimental Eye Research ·Kathleen Boesze‐Battaglia, Andrew F.X. Goldberg, Janice H. Dispoto, Madan Katragadda, Gregory Cesarone, Arlene D. Albert	30
18	Assembly of a Polytopic Membrane Protein Structure from the Solution Structures of Overlapping Peptide Fragments of Bacteriorhodopsin 2001 ·Biophysical Journal ·Madan Katragadda, James L. Alderfer, Philip L. Yèagle	66
19	Thermal Destabilization of Rhodopsin and Opsin by Proteolytic Cleavage in Bovine Rod Outer Segment Disk Membranes 2001 ·Biochemistry ·(unknown), Madan Katragadda, Arlene D. Albert	31
20	Solution structure of the loops of bacteriorhodopsin closely resembles the crystal structure 2000 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Madan Katragadda, James L. Alderfer, Philip L. Yèagle	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact